← Back to Search

Wearable short wavelength light therapy for Tourette Syndrome

N/A
Waitlist Available
Led By Emily J Ricketts, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights

Study Summary

This trial looks at whether a wearable light therapy device can help improve symptoms in young people with Tourette's Disorder by regulating their circadian rhythms.

Eligible Conditions
  • Tourette Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dim Light Melatonin Onset
Yale Global Tic Severity Scale (YGTSS)
Secondary outcome measures
Children's Morningness-Eveningness Preferences Scale (CMEP)
Clinical Global Impression-Improvement (CGI-I) Scale
Parent Tic Questionnaire (PTQ)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Wearable short wavelength light therapyExperimental Treatment1 Intervention
Wearable short wavelength light therapy

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,541 Previous Clinical Trials
10,267,028 Total Patients Enrolled
4 Trials studying Tourette Syndrome
200 Patients Enrolled for Tourette Syndrome
National Institute of Mental Health (NIMH)NIH
2,816 Previous Clinical Trials
2,670,884 Total Patients Enrolled
13 Trials studying Tourette Syndrome
3,304 Patients Enrolled for Tourette Syndrome
Emily J Ricketts, PhDPrincipal InvestigatorUniversity of California, Los Angeles
2 Previous Clinical Trials
45 Total Patients Enrolled
2 Trials studying Tourette Syndrome
45 Patients Enrolled for Tourette Syndrome
~5 spots leftby Jun 2025